President Trump has proposed construction of an arch at the edge of Washington in the style of the Arc de Triomphe as part of the lead-up to the nation’s 250th anniversary. By Aishvarya Kavi Reporting ...

Repaired coarctation of the aorta (CoA)—either simple or as part of complex congenital heart disease—can be associated with long‐term sequelae such as recoarctation of the aorta (reCoA) or arterial ...

Background In patients with dextro-transposition of the great arteries, cardiovascular interventions and complications are common after the arterial switch operation (ASO). While complex ...

The Nexus aortic arch stent graft system is made of nitinol and polyester. [Image from Endospan] Endospan today announced the presentation of 30-day results from a study evaluating its Nexus aortic ...

May 5, 2025—Endospan announced 30-day results of the statistical Dissection primary arm from the TRIOMPHE investigational device exemption (IDE) clinical study, which is evaluating the company’s Nexus ...

Background: Recurrent coarctation of the aorta (re-CoA) is a well-known although not fully understood complication after surgical repair, typically occurring in 10%–20% of cases within months after ...

The Nature Index 2024 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

All available blood pressure (BP) recordings postrepair were abstracted from the patient's medical record. Following standard practice at our institution, right arm BP was recorded while seated using ...

Patients with bicuspid aortic valve (BAV) and those with BAV and concomitant coarctation of the aorta had larger aortic root and ascending aortic size as compared to those patients with isolated ...

Introduction Endovascular repair of the entire aortic arch provides treatment opportunities for patients with aortic arch lesions who are intolerant to open surgery. However, the complex anatomical ...

January 30, 2024—Endospan, an Israel-based company focused on off-the-shelf endovascular repair of aortic arch disease, announced the presentation of 30-day results of the first 22 patients enrolled ...